More Orthocell Ltd news
Orthocell LtdASX: OCC

OrthoATI Tendon Clinical Study Success

Dec 7, 2021 at 11:09 PM EST · Issued by Orthocell Ltd

Filed with ASX · Dec 7, 2021 at 11:09 PM EST

On 6ix: 6ix.com/news/orthoati-tendon-clinical-study-success

Orthocell Ltd has released a press release.

View Attachment

6ix hasn’t read this filing yet.

Orthocell Ltd on 6ix

Story so far

  • Orthocells Ortho-ATI Shows 87.5% Success RateJul 9, 2020
  • Orthocells Ortho-ATI shows 82% success rateFeb 13, 2019

Earlier from Orthocell

  • Ortho-ATI Shoulder Tendon Study Database LockNov 14, 2021
  • Application for quotation of securities - OCCNov 9, 2021
  • Positive Data for CelGro Collagen Rope in ACL ReconstructionSep 14, 2021
  • OCC Secures Patents for Suture-Less Repair of Soft TissueSep 7, 2021
  • Ortho-ATI Shoulder Tendon Study Update RevisedAug 31, 2021

Later from Orthocell

  • Successful SmrtGraft Shoulder Study PublishedDec 15, 2021
  • Striate US Market Entry UpdateFeb 27, 2022
  • Regulatory Approval for Remplir Nerve Repair DeviceMar 20, 2022
  • Notification regarding unquoted securities - OCCApr 21, 2022
  • Orthocell Receives A$2.1m R&D Tax Incentive RefundJun 2, 2022
All Orthocell news releases↗

Follow Orthocell into a list and get an email when it puts out news.

Follow Orthocell
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer